Serum butyrylcholinesterase activity and phenotype associations with lipid profile in stroke patients

Clinical Biochemistry

Volumn 42, Issue 3, 2009, Pages 210-214

  Vaisi Raygani, Asad ^a,c   Tavilani, Heidar ^b   Zahrai, Mahine ^c   Rahimi, Zohreh ^a   Sheikh, Nasrin ^b   Aminian, Mahdi ^c   Pourmotabbed, Tayebeh ^d  

^a KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Acetylcholine; Acetylcholinesterase; Butyrylcholinesterase; Lipids; Stroke

Indexed keywords

CHOLESTEROL; CHOLINESTERASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE FREQUENCY; HUMAN; MALE; PHENOTYPE; PRIORITY JOURNAL; STROKE PATIENT; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; AGED, 80 AND OVER; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CHOLESTEROL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; LIPIDS; LIPOPROTEINS; MALE; MIDDLE AGED; STROKE; TRIGLYCERIDES;

EID: 58349121667     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.10.025     Document Type: Article

References (41)

1. Murray C.J., and Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 3 (1997) 1269-1276
2. Yamada M., Sodeyama N., Itoh Y., et al. Butyrylcholinesterase K variant and cerebral amyloid angiopathy. Stroke 29 (1998) 2488-2490
3. Sharma P. Genes for ischemic stroke: strategies for their detection. J. Hypertens. 14 (1996) 277-285
4. Casas J.P., Hingorani A.D., Bautista L.E., and Sharma P. Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18,000 cases and 58,000 controls. Arch. Neurol. 61 (2004) 1652-1661
5. Ioannidis J.P., Ntzani E.E., and Trikalinos T.A. "Racial" differences in genetic effects for complex diseases. Nat. Genet. 36 (2004) 1312-1318
6. Morgan L., and Humphries S.E. The genetics of stroke. Curr. Opin. Lipidol. 16 (2005) 193-199
7. Saidi S., Slamia L.B., Ammou S.B., Mahjoub T., and Almawi W.Y. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels. J. Stroke Cerebrovasc. Dis. 6 4 (2007) 160-166
8. Mesulam M.M., and Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann. Neurol. 36 (1994) 722-727
9. Geula C., and Mesulam M.M. Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9 Suppl 2 (1995) 23-28
10. Darvesh S., Martin E., Walsh R., and Rockwood K. Differential effects of lipid-lowering agents on human cholinesterases. Clin. Biochem. 37 1 (2004) 42-49
11. Paolucci S., and De Angelis D. New developments on drug treatment rehabilitation. Clin. Exp. Hypertens. 28 3-4 (2006) 345-348
12. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Neuroscience 4 (2003) 131-137
13. Mesulam M.M. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
14. Geula C., and Mesulam M.M. Cholinesterases and the pathology of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 9 (1995) 23-28
15. La Du B.N., Bartels C.F., Nogueira C.P., et al. Phenotypic and molecular biological analysis of human butyrylcholinesterase variants. Clin. Biochem. 29 2 (1996) 165-169
16. Whittaker M. In: Backman Karger L. (Ed). Cholinesterase monographs in humans. Genetics 11 (1986), Basel RL, Switzerland 1-90
17. Bartels C.F., James K., and La Du B.N. DNA mutations associated with the human butyrylcholinesterase J-variant. Am. J. Hum. Genet. 50 5 (1992) 1104-1114
18. Vaisi-Raygani A., Rahimi Z., Kharazi H., et al. Determination of butyrylcholinesterase (BChE) phenotypes to predict the risk of prolonged apnea in persons receiving succinylcholine in the healthy population of western Iran. Clin. Biochem. 40 (2007) 629-633
19. Cote R., Battista R.N., Wolfson C., Boucher J., Adam J., and Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology 39 (1989) 638-643
20. Calderon-Margalit R., Adler B., Abramson J.H., Gofin J., and Kark J.D. Butyrylcholinesterase activity, cardiovascular risk factors, and mortality in middle-aged and elderly males and females in Jerusalem. Clin. Chem. 52 5 (2006) 845-852
21. Appleyard M.E., and McDonald B. Acetylcholinesterase and butyrylcholinesterase activities in cerebrospinal fluid from different levels of the neuraxis of patients with dementia of the Alzheimer type. J. Neurol. Neurosurg. Psychiatry 55 11 (1992) 1074-1078
22. Huff F.J., Maire J.C., Growdon J.H., Corkin S., and Wurtman R.J. Cholinesterases in cerebrospinal fluid. Correlations with clinical measures in Alzheimer's disease. J. Neurol. Sci. 72 2-3 (1986) 121-129
23. Wester P., Puu G., Reiz S., Winblad B., and Wester P.O. Increased monoamine metabolite concentrations and cholinesterase activities in cerebrospinal fluid of patients with acute stroke. Acta Neurol. Scand. 76 6 (1987) 473-479
24. Shen Z.X. The significance of the activity of CSF cholinesterases in dementias. Med. Hypotheses 47 5 (1996) 363-376
25. Perry E.K., Perry R.H., Blessed G., and Tomlinson B.E. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol. Appl. Neurobiol. 4 4 (1978) 273-277
26. Shen Z.X. CSF cholinesterase activity in demented and non-demented subjects. NeuroReport. 9 3 (1998) 483-488
27. Ott E.O., Abraham J., Meyer J.S., Achari A.N., Chee A.N., and Mathew N.T. Disordered cholinergic neurotransmission and dysautoregulation after acute cerebral infarction. Stroke 6 (1975) 172-180
28. Schetinger M.R., Bonan C.D., Frassetto S.S., et al. Preconditioning to global cerebral ischemia changes hippocampal acetylcholinesterase in the rat. Biochem. Mol. Biol. Int. 47 (1999) 473-478
29. Sa'ez-Valeroa J., Gonza'lez-Garci{dotless}' C., and Cen ̃a V. Acetylcholinesterase activation in organotypic rat hippocampal slice cultures deprived of oxygen and glucose. Neurosci. Lett. 348 (2007) 123-125
30. Darvesh S. Cholinesterases in cardiac ganglia and modulation of canine intrinsic cardiac neuronal activity. J. Auton. Nerv. Syst. 71 (1998) 75-84
31. Darvesh S., and Hopkins D.A. Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus. J. Comp. Neurol. 463 1 (2003) 25-43
32. Tanne D., Koren-Morag N., Graff E., et al. Blood lipids and first-ever ischemic stroke/transient ischemic attack in the Bezafibrate Infarction Prevention (BIP) Registry: high triglycerides constitute an independent risk factor. Circulation 104 (2001) 2892-2897
33. Jurgens G., Taddei-Peters W.C., Koltringer P., et al. Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 26 (1995) 1841-1848
34. Sacco R.L., Benson R.T., Kargman D.E., et al. High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan stroke study. JAMA 285 (2001) 2729-2735
35. Tanizaki Y., Kiyohara Y., Kato I., et al. Incidence and risk factors for subtypes of cerebral infarction in a general population: the Hisayama study. Stroke 31 (2000) 2616-2622
36. Sridhar G.R., Nirmala G., Apparao A., et al. Serum butyrylcholinesterase in type 2 diabetes mellitus: a biochemical and bioinformatics approach. Lipid Health Dis. 4 (2005) 18
37. Raygani A.V., Zahrai M., Solt Anzadeh A., Doosti M., Javadi E., and Pourmotabbed T. Analysis of association between butyrylcholinesterase K variant and apolipoprotein E genotypes in Alzheimer's disease. Neurosci. Lett. 371 (2004) 142-146
38. Vaisi-Raygani A., Rahimi Z., Entezami H., et al. Butyrylcholinesterase K variants increase the risk of coronary artery disease in the population of western Iran. Scand. J. Clin. Lab. Invest. 68 No (2008) 123-129
39. Giacobini E. In: Giacobini E. (Ed). Cholinesterases and cholinesterase inhibitors (2000), Martin Dunitz Ltd, London 181-226
40. Mesulam M.M. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
41. Kostovic I., and Goldman-Rakic P.S. Transient cholinesterase staining in the mediodorsal nucleus of the thalamus and its connections in the developing human and monkey brain. J. Comp. Neurol. 219 (1983) 431-447